GeoVax Labs, Inc. New
Here’s whether GeoVax Labs, Inc. New (GOVX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Caution.
Positives: above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+2.68% over 10 days); 3-month momentum positive (+127.5%). Concerns: trading below the 200-day MA (long-term downtrend); RSI 81 — overbought, elevated pullback risk; weak 1-year return of -85.7%; rising volume on a downtrend (distribution, 2.90x avg). Currently 89.5% off its 52-week high. Score: -1/7.
GOVX is trading below its 200-day MA ($7.85) — a key warning sign the longer-term trend is under pressure. With an RSI of 80.9, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of -85.7% compares to +27.9% for SPY (trailed the market by 113.6%). The current 89.5% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.